Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its
broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the …

Background Febuxostat and allopurinol are urate-lowering therapies used to treat patients
with gout. Following concerns about the cardiovascular safety of febuxostat, the European …

Aims The key role of inflammation in the pathogenesis of coronary artery disease (CAD) is
an urgent call for innovative treatments. Several trials have proposed colchicine as a …

Aims Inflammation plays a central role in the pathogenesis and clinical manifestations of
atherosclerosis. Randomized controlled trials have investigated the potential benefit of …

Abstract Purpose of Review Recent studies have demonstrated an important role for
inflammation in the pathogenesis of atherosclerotic cardiovascular disease. Several studies …

Background: Inflammation plays a key role in atherosclerotic plaque destabilization and
adverse cardiac remodeling. Recent evidence has shown a promising role of colchicine in …

Background: Evidence from recent studies has shown the benefits of colchicine for patients
with coronary artery disease. The aim was to assess the effect of colchicine treatment on …

To evaluate the efficacy and safety of colchicine for secondary prevention of coronary heart
disease (CHD), relevant randomized controlled trials (RCTs) were identified by searching …

Objectives: To evaluate the effect of Yugengtongyu granules on reducing the incidence of
adverse cardiovascular events and improving quality of life (QOL) in patients with stable …

This editorial refers to 'Efficacy and safety of colchicine for the prevention of major
cardiovascular and cerebrovascular events in patients with coronary artery disease: a …